Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Genmab cancer therapy shows promise in phase I/II trial
In the trial, 27 patients who had previously failed standard therapies were divided into six dose groups receiving IV infusions of HuMax-EGFr at doses of 0.15, 0.5, 1,
In the trial, 27 patients who had previously failed standard therapies were divided into six dose groups receiving IV infusions of HuMax-EGFr at doses of 0.15, 0.5, 1,
The FDA approved Mycamine (micafungin sodium) in March 2005 for the prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation and the treatment of esophageal candidiasis.
Results from two published clinical trials suggest that symptoms produced by non-steroidal anti-inflammatory drugs (NSAIDs), such as moderate to severe pain, burning and discomfort in the upper abdomen,
Cephalon is required to pay an additional $40 million of cash payments upon the achievement of certain regulatory milestones. At the close of the transaction, Salmedix is expected
PXD101 is a histone deacetylase (HDAC) inhibitor being co-developed by CuraGen and TopoTarget for the treatment of solid and hematologic cancers. It is currently in a phase II
A total of 829 older adults (aged 64-93 years) were enrolled in a randomized, double-blind, five-week study. Study participants completed next-morning sleep questionnaires regarding their previous night’s sleep
The collaboration, Access’ third oral drug delivery research collaboration, is aimed at combining Access’ proprietary vitamin B12 oral drug delivery technology with Hunter-Fleming’s Alzheimer’s disease drug candidate, Oligotropin
This study is part of a series of single agent and combination studies of the vascular endothelial growth factor (VEGF) trap in a variety of cancer types. Regeneron
Rincon has already demonstrated the technical feasibility of using microalgae to produce antibodies at laboratory scale. The purpose of the collaboration between Mera and Rincon is to use
The study was conducted in animal models by researchers at Alexion Pharmaceuticals, the Yale University School of Medicine and the Brigham and Women’s Hospital. Alexion believes the results